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Expression Analysis of the Imprinted Gene Transketolase-like 1 in Mouse and Human 
 
Amy Frances Friss 
University of Connecticut 
 
Abstract 
Genomic imprinting is an epigenetic phenomenon resulting in differential gene 
expression based on parental origin. Recently, transketolase-like 1 (TKTL1) has been 
identified as an X-linked imprinted gene. TKTL1 functions in the nonoxidative branch of 
the pentose phosphate pathway (PPP), which maintains glutathione in a reduced state 
through the generation of NADPH. Previous studies on transaldolase, the other critical 
enzyme in the nonoxidative branch of the PPP, suggest that TKTL1 may affect the cell’s 
ability to reduce glutathione. This study provides evidence that TKTL1 overexpression 
inhibits glutathione reduction. Intriguingly, aberrant glutathione levels are associated 
with autism. Additionally, studies involving Turner syndrome females found that 
differences in social behavior could distinguish females expressing the maternal X 
chromosome from those expressing the paternal X chromosome. This led researchers to 
hypothesize the influence of an X-linked imprinted gene in autism. Accordingly, this 
study compared TKTL1 expression levels in autistic patients versus their unaffected 
siblings. The results suggest that further studies are required. 
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Chapter 1: Background Information 
 
1.1 Epigenetics and Imprinting 
 Genomic imprinting is an epigenetic phenomenon resulting in parent-of-origin 
gene expression. Epigenetic mechanisms mediate genomic imprinting, leaving the DNA 
sequence unchanged. These mechanisms primarily include DNA methylation patterns 
and histone modifications. The epigenetic marking of an imprinted gene’s alleles 
designate their parental origin, allowing for appropriate expression patterns in the soma
1
.   
 Differential DNA methylation is the hallmark of imprinted genes. A differentially 
methylated region (DMR) is only methylated on one parental allele, typically on the 
cytosine of CpG dinucleotides
2
. Often, DMRs constitute imprinting control regions 
(ICRs)
2
. The imprint is established in the germline and is maintained throughout genome-
wide demethylation during preimplantation development
1
. Deletion of an imprinted 
gene’s ICR can result in loss of imprinted gene expression or reversion to biallelic 
expression
1
. 
 DNA methylation is regulated by DNA methyltransferases (DNMTs), which are 
classified as de novo methyltransferase or maintenance methyltransferase. DNMT3A and 
DNMT3B are the de novo methyltransferases, assisted by the DNMT3L protein. Though 
it is homologous to DNMT3A and DNMT3B, DNMT3L has no catalytic activity
3
 but is 
still a regulator of imprint establishment
4
. Research demonstrated DNMT3L association 
with DNMT3A only in species in which imprinting occurs, suggesting that DNMT3L 
acquisition may have been related to the evolution of imprinting.
5
 Together, DNMT3A 
and DNMT3L are responsible for de novo methylation of most ICRs. Hemimethylated 
2 
 
DNA is methylated by DNMT1, the enzyme necessary for maintaining DNA methylation 
at imprinted loci and across the genome. 
Histones exhibit post-translational modifications including methylation and 
acetylation. Methylation of specific amino acid residues occurs via histone 
methyltransferase. Actively transcribing regions are typically methylated on arginine 
residues whereas methylation of lysine (K) residues is typically associated with 
repression, except for H3K4 trimethylation
6
 and H4K20 monomethylation
7
 which result 
in active transcription. Histones are acetylated or deacetylated using histone 
acetyltransferase (HAT) or histone deacetylase (HDAC), respectively. Upon acetylation, 
chromatin is transformed into a more relaxed structure that is associated with more 
actively transcribing DNA. The acetyl group carries a negative charge that interacts with 
the positively charged histones to create a neutral environment.  A neutral environment 
decreases the histones’ interaction with the negatively charged DNA, providing greater 
accessibility for transcription factors.  
 Chromatin packages DNA into a structure that fits into the cell and is strong for 
support during mitosis and meiosis. Chromatin is composed of histone octamers, dimers 
of subunits H2A, H2B, H3 and H4, wrapped in DNA, forming a nucleosome
8
. The 
different states of chromatin control gene expression and DNA replication: 
heterochromatin is associated with non-transcribing regions; euchromatin with actively 
transcribing regions.   
 Imprinted genes are generally found in 1Mb clusters controlled by one ICR
1
. 
Clusters are typically regulated in one of two ways, including use of an insulator to 
control access to the shared regulatory elements of the cluster and silencing of the cluster 
3 
 
by noncoding RNA (ncRNA)
1
. The H19/Igf2 locus is controlled by the insulator 
mechanism, while ncRNA regulates the Igf2r cluster in mouse
9
. 
 H19 is a paternally imprinted (maternally expressed) gene on mouse chromosome 
7, coding for a 2.2Kb non-coding RNA
10
. Insulin-like growth factor 2 (Igf2) is a 
maternally imprinted (paternally expressed)
11,12
 gene influencing fetal growth and is 
found within the same cluster as H19.  Both genes share an enhancer
13
 and are controlled 
by the same ICR
14,15
. On the maternal allele the ICR binds CTCF, a protein that mediates 
insulator activity at the β-globin locus16. CTCF binding blocks interaction of Igf2 with the 
enhancers, while H19 retains access and proceeds with transcription
17
.  The ICR is 
methylated on the paternal allele, blocking CTCF binding and preventing H19 from 
interacting with the enhancers while Igf2 maintains interaction
9
 (Figure 1.1).  
 
 
  Figure 1.1 Imprinted H19/Igf2 cluster. Figure adapted from Bartolomei et al
1
. 
  
More commonly, ncRNAs appear to regulate imprinting in clusters
18
, as in the 
insulin-like growth factor 2 receptor (Igf2r) cluster on mouse chromosome 17A
19
 (Figure 
1.2).The Igf2r cluster consists of maternally expressed genes Igf2r, solute carrier 22a2 
and 22a3 (Slc22a22 and Slc22a3, respectively),  paternally expressed antisense Igf2r 
4 
 
RNA (Airn) and a few non-imprinted genes. Airn is a 108 kb ncRNA that is arranged in 
an antisense orientation to Igf2r, with its promoter located in the cluster’s ICR1. On the 
maternal chromosome the ICR is hypermethylated, preventing Airn transcription but 
allowing transcription of Igf2r, Slc22a22 and Slc22a3. On the paternal copy, the ICR is 
unmethylated; however the Igf2r promoter is methylated after transcription initiation of 
the imprinted gene. Igf2r promoter methylation leads to transcription of Airn while the 
other 3 imprinted genes in the cluster are not transcribed. While it is known that Airn 
expression leads to gene silencing, the mechanism remains to be determined
1
. 
 
 
   Figure 1.2 Imprinted Igf2r cluster. Figure adapted from Bartolomei et al
1
. 
 
1.2 X-Linked Imprinting 
 While most imprinted genes are found on autosomes, a subset has been identified 
on the X chromosome
20
. Most X-linked genes, imprinted and non-imprinted, are subject 
to X chromosome inactivation in female mammals; one X chromosome in each cell is 
randomly inactivated as a form of dosage compensation to equate for the single 
(maternal) X chromosome in male cells. A counting mechanism ensures that each cell 
maintains only one active X chromosome per diploid cell
21
. The inactive X chromosome 
is a Barr body and is visualized in somatic cells as compact chromatin.  
5 
 
X chromosome inactivation is mediated by the X chromosome inactivation center 
(XIC) which contains several elements that may play a role in inactivation. One such 
element is the X-chromosome-controlling element (XCE)
22
. The X chromosome carrying 
the stronger XCE is more likely to remain active, leading to unequal X inactivation. 
Other elements include the genes XIST (X (inactive)-specific transcript)
23
 and TSIX (X 
(inactive)-specific transcript, antisense)
24
. XIST encodes a 17 Kb noncoding RNA 
molecule that accumulates along the X chromosome containing the active XIST gene, 
resulting in inactivation of most genes on that chromosome with few exceptions. TSIX, 
also a noncoding transcript, is synthesized on the strand antisense to XIST and at the onset 
of X-inactivation extends along the entire XIST gene of the X chromosome destined to 
remain active. While it is known that TSIX regulates XIST expression in cis, the 
mechanism by which this occurs is undetermined. 
X chromosome inactivation complicates X-linked imprinting by influencing the 
expression level of X-linked imprinted genes in females. For example, a paternally 
imprinted gene will be expressed in approximately half of a female’s cells. The other half 
of cells with an inactive maternal X chromosome will have low, if any, expression of the 
paternally imprinted gene. In comparison, males will express this paternally imprinted 
gene from their single (maternal) X chromosome in every cell. Consequently, males will 
exhibit higher expression of this gene than females.  The expression difference may 
contribute to sex-specific differences seen between males and females. 
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1.3 Search for X-Linked Imprinted Genes 
 A search for X-linked imprinted genes was performed using a mouse model for 
Turner syndrome (39,X
m
 and 39,X
p
)
25
. The search led to the gene X-linked lymphocyte 
regulated (Xlr), of which fifteen paralogs have been identified. Of these fifteen, three 
have been identified as imprinted genes: Xlr3b, Xlr4b and Xlr4c are repressed on the 
paternal X chromosome
25
. The Xlr3 and Xlr4 gene clusters are in a region of high 
homology that is highly conserved between mouse and human. In humans, this region is 
located near the end of Xq28, however no human homologs of any Xlr gene have been 
identified. In addition, the function of Xlr proteins remains unclear.   
Following identification of the imprinted mouse Xlr genes, Dr. Addie May 
Nesbitt expanded the search for X-linked imprinted genes. Because imprinted genes are 
typically found in clusters, her search included four genes in a region 1 Mb downstream 
of the Xlr locus and one gene 2Mb upstream: Filamin alpha or Actin binding protein 
280/Abp280 (Flna), B cell receptor associated protein 31 (Bcap31), Inhibitor of kappa B 
kinase gamma (Ikbkg), Transketolase-like 1 (Tktl1) and Cd99 antigen-like 2 or Xap89 
(Cd99l2). All but one gene displayed biallelic expression in E9.5 embryo, E9.5 placenta 
and E14.5 liver. The exception was Tktl1 in liver, where there was a statistically 
significant difference between the different genotypes. 39,X
m
 Tktl1 expression was about 
14-fold higher than 39,X
p
, while  40,XX expression was in between 39,X
m
 and 39,X
p
 
with the expression level  closer to 39,X
p
. Since X-linked imprinted genes have been 
implicated in neurocognitive disorders, a variety of brain subregions were assayed as well 
and analysis found increased Tktl1 expression in brain subregions of 39,X
m
. 
Subsequently, Tktl1 became the focus of X-linked imprinting studies. 
7 
 
Upon confirmation of Tktl1 imprinting in mice, the search for a human ortholog 
began. Human brain subregions from a 19 week 40,XX female indicate tissue specific 
imprinting of TKTL1. The hypothalamus, midbrain, frontal cortex and thalamus all 
displayed higher TKTL1 expression from one X chromosome while the temporal cortex 
did not show an imprint. Assays using human lymphoblastoid cells from Turner 
syndrome individuals demonstrated higher TKTL1 expression from the maternal X 
chromosome. Taken together, these results indicate that Tktl1/TKTL1 is paternally 
imprinted in both mouse and human.  
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CHAPTER 2: TKTL1 Overexpression Studies 
 
2.1 Background Information 
Pentose Phosphate Pathway 
Glucose metabolism in the cell occurs via two main biochemical pathways: the 
Embden-Meyerhof pathway and the pentose phosphate pathway (PPP). The Embden-
Meyerhof pathway degrades glucose to provide lactic acid and ATP in anaerobic 
conditions. The PPP exists in the cytoplasm of the cell (Figure 2.1), producing the 
reducing equivalent NADPH (reduced nicotinamide adenine dinucleotide phosphate) and 
ribose for ribose nucleic acid. The PPP consists of two branches: the oxidative branch 
and the nonoxidative branch. The oxidative branch of the PPP is unidirectional, whereas 
the nonoxidative branch is fully reversible. NADPH is produced in the oxidative branch 
via the enzymes glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate 
dehydrogenase (6PGD). In the nonoxidative branch, the forward reactions produce 
glyceraldehyde-3-phosphate and fructose-6-phosphate while the reverse reactions 
produce ribose-5-phosphate. 
 Transaldolase (TAL) and Transketolase (TK) comprise the enzymes of the PPP’s 
nonoxidative branch. TAL catalyzes two reactions: glyceraldehydes-3-phosphate to 
fructose-6-phosphate; sedoheptulose-7-phosphate to erythrose-4-phosphate. TK catalyzes 
the following: xylulose-5-phosphate and ribose-5-phosphate to sedoheptulose-7-
phosphate or glyceraldehydes-3-phosphate; xylulose-5-phosphate and erythrose-4-
phosphate to glyceraldehydes-3-phosphate or fructose-6-phosphate. Conflicting results 
have been obtained as to which is the rate-limiting enzyme of this branch
26,27,28,29
. 
9 
 
 
 
Figure 2.1 The pentose phosphate pathway of glucose metabolism. The oxidative branch 
begins at glucose-6-phosphate and produces ribulose-5-phosphate, which leads into the 
nonoxidative branch. 
 
10 
 
 TK transfers a two carbon unit (1,2-dihydroxyethyl) in a two-substrate reversible 
reaction from ketose phosphates to aldose phosphates. TK is a thiamine-dependent 
transferase and therefore requires thiamine diphosphate, along with Ca
2+
, as 
cofactors
30,26
. The forward reactions catalyzed by TK produce glyceraldehyde-3-
phosphate and fructose-6-phosphate which are utilized by glycolytic pathways or 
converted into glucose-6-phosphate and reintroduced into the PPP. In the reverse 
reaction, TK produces ribose-5-phosphate which is necessary for nucleic acid synthesis. 
 TK has been implicated in neurodegenerative diseases, diabetes and cancer
31
. 
Thiamine deficiency in humans leads to the neuropsychiatric disorder Wernicke’s 
encephalopathy (WE), which is encountered in chronic alcoholics and patients with 
impaired nutrition associated with gastrointestinal disease or AIDS
32. In Alzheimer’s 
disease, varied TK proteins with different isoelectric points have been detected. Altered 
TK activity is not implicated in other neurological diseases, making this characteristic for 
Alzheimer’s disease and a potential biomarker33. Diabetes patients have high blood 
glucose levels resulting in nonenzymatic glycation which causes vascular complications, 
neuropathy and retinopathy by producing advanced glycation end products
34
. Treatment 
with vitamin B1 (thiamine derivative benfotiamine) supplements activates TK, blocking 
three major pathways of hyperglycemic damage
35
. In cancer, some cells produce more 
than 85% of ribose for nucleic acid synthesis directly or indirectly from the nonoxidative 
branch of the PPP due to increased enzymatic activity
36
. Specifically, transketolase-like 1 
upregulation occurs in cancer cells
37
, providing a novel target for cancer patient nutrition 
and treatment. 
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Transketolase-like 1 
 One transketolase gene, transketolase (TK), and two transketolase-like genes, 
transketolase-like 1 (TKTL1) and transketolase-like 2 (TKTL2), have been identified. 
TKTL1, initially described by Coy et al. in 1996 as a transketolase-related gene, contains 
a stop codon in a putative exon which causes deletion of that exon. The deletion mutates 
one of the two thiamine binding sites in the gene. Because of the pseudoexon it was 
thought that TKTL1 was a pseudogene, however Coy et al. later demonstrated 
transketolase activity
31
. TKTL1 encodes a tissue-specific spliced exon, causing formation 
of TKTL1 transcripts which produce full length and smaller proteins and encode tissue-
specific protein isoforms. While TKTL1 acts as a transketolase, it also has altered 
enzymatic activity. Coy et al. found that TKTL1 has broader substrate utilization than 
TK, as well as an enhanced one-substrate reaction
31
.  
TKTL1 is the sole transketolase upregulated in tumor cells, potentially due to its 
location; Xq28 is one of a few regions activated in malignancies and during the cell 
cycle
39,40
. Cancer cells naturally overexpressing TKTL1 have an increased amount of 
reduced glutathione (GSH) and NADPH compared to similar cells in which TKTL1 has 
been silenced with siRNA
41
. In cancer cells, upregulation of TKTL1 is thought to increase 
flow through the oxidative branch of the PPP, leading to increased NADPH production 
and subsequently increased GSH production. The GSH increase would neutralize free 
radicals, characteristic of cancer cells, allowing the cancer cell to combat oxidative stress. 
Silencing TKTL1, however, causes the cancer cell to succumb to oxidative stress and 
apoptose. 
  
12 
 
2.2 Overexpression Studies 
 Functional analysis of TKTL1 overexpression remains to be performed. 
Specifically, the effect of TKTL1 overexpression on oxidative stress has not been studied. 
The effect of TAL overexpression, however, has been analyzed.  
 TAL overexpression in Jurkat human T cells leads to decreased enzymatic 
activities of G6PD and 6PGD and decreased NADPH and GSH levels
42
. Based on these 
results and others, Banki et al. proposed that TAL plays a critical role in regulating the 
balance between the oxidative and nonoxidative branches of the PPP
42
. I hypothesized 
that similar results would be obtained upon overexpression of TKTL1, coding for the 
other critical enzyme of the nonoxidative branch of the PPP.  
I aimed to determine the effect of TKTL1 overexpression on oxidative stress. 
Overall, I hypothesized that TKTL1 overexpression would lead to increased cellular 
oxidative stress as measured by the effect of TKTL1 overexpression on GSH levels. 
NADPH and G6pdx expression levels were also analyzed in effort to determine TKTL1’s 
effect on the PPP. An immortalized mouse hippocampal cell line (HT-22, gift from the 
laboratory of Dr. Walikonis) was used for transfection. The HT-22 cell line is a 
glutamate-sensitive subclone from an HT-4 cell line. HT-4 cells were derived from 
mouse neuronal tissue immortalized with a temperature-sensitive SV40 T-antigen that 
adopted properties of differentiated neuronal cells at the nonpermissive temperature. 
TKTL1 was overexpressed by transfecting HT-22 cells with the human TKTL1 gene, 
allowing visualization of the resulting protein by Western blot analysis separately from 
the mouse protein based on antibody specificity and thus demonstrating TKTL1 
overexpression. 
13 
 
 Construct Formation 
 pCAGGS (gift from the laboratory of Dr. LoTurco), a 4801bp  plasmid with a 
constitutive chicken β-actin promoter allowing for constant expression, was used for 
transfection (Supplemental Figure 1). The human TKTL1 sequence was inserted into the 
vector by restriction enzyme digestion and ligation (Protocol 1) and selected for in 
Escherichia coli by the ampicillin resistance cassette on pCAGGS. 
 
Transfection 
 TKTL1 was overexpressed in HT-22 cells by transfection using Lipofectamine™ 
LTX (Protocol 2). A GFP-pCAGGS construct (gift from the laboratory of Dr. Walikonis) 
was co-transfected with the hTktl1-pCAGGS construct in order to visualize transfection 
efficiency. Green fluorescent protein (GFP) was produced in the cells by the GFP-
pCAGGS construct, presumably representing the transfection efficiency of hTktl1-
pCAGGS as well. The images in Table 2.1, captured by an inverted microscope, illustrate 
the GFP expression and the confluency of HT-22 cells on the day they were harvested. 
There appears to be high transfection efficiency.  
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Trial Control Sample 
1 NA NA 
 
2 
 
 
 
 
 
3 NA NA 
 
4A 
 
 
 
 
 
 
4B 
 
 
 
 
 
 
5A 
 
 
 
 
15 
 
 
5B 
 
 
 
 
 
6A NA NA 
6B NA NA 
 
7A 
 
 
 
 
 
 
7B 
 
 
 
 
 
 
7C 
 
 
 
 
 
 
16 
 
 
8A 
 
 
 
 
 
 
8B 
 
 
 
 
 
 
8C 
 
 
 
 
 
 
8D 
 
 
 
 
 
 
 
 
 
 
17 
 
 
9A 
 
 
 
 
 
9B NA NA 
 
9C 
 
 
 
 
 
 
9D 
 
 
 
 
 
 
Table 2.1 The first column contains the transfection trial designation. The second column 
contains images of HT-22 cells transfected with GFP-pCAGGS and pCAGGS (control). 
In the third column are images of HT-22 cells transfected with GFP-pCAGGS and 
hTktl1-pCAGGS (sample). Each box contains images of transfected HT-22 cells without 
visualizing the fluorescence on top and images showing the GFP expression on bottom, 
thereby indicating the expression of control or hTktl1-pCAGGS. “NA” means that 
images were not available for the indicated trials. 
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Western Blot Analysis 
 After the transfected HT-22 cells were harvested a Western blot was performed to 
confirm the absence and presence of human TKTL1 in control and sample cells, 
respectively (Protocol 3). Goat anti-human TKTL1 bound to TKTL1 in hTktl1-pCAGGS 
transfected cells, but not in control cells, confirming expression of human TKTL1 only in 
hTktl1-pCAGGS transfected cells (Table 2.2). Therefore, overexpression of TKTL1 is 
indicated in cell samples and not controls. 
 
Trial Western Blot Image 
 
1 
                                           Control                      Sample 
 
 
2 NA 
 
3 
                                       Control                         Sample 
 
 
 
4A 
                                       Control                     Sample 
 
 
 
4B 
                                      Control                          Sample 
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5A 
                                         Control                     Sample 
 
 
 
5B 
                                                             Control                        Sample 
 
 
 
6A 
                                           Control                   Sample 
 
 
 
6B 
                                         Control                      Sample 
 
 
 
7 
    Control A     Sample A      Control B     Sample B   Control C   Sample C 
 
 
 
8 
                 Control A*    Sample A                         Control B     Sample B 
 
 
           *Sample A spilled over into the well for Control A upon loading the gel. 
             This control/sample pair was excluded from use in future assays. 
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8 
                 Control C        Sample C                          Control D    Sample D 
 
 
 
9 
                   Control A         Sample A             Control B           Sample B 
 
 
 
9 
                    Control C      Sample C              Control D           Sample D 
 
 
 
Table 2.2 Detection of the human TKTL1 protein by Western blot in HT-22 cell lines 
after transfection with GFP-pCAGGS and control (pCAGGS) or hTktl1-pCAGGS 
(sample). The primary antibody was specific to human TKTL1 and the protein band size 
is 65kDa. Primary and secondary antibodies bound only to the sample transfected with 
hTktl1-pCAGGS. A negative control with secondary antibody only was performed with 
all controls and samples and resulted in a lack of protein bands (data not shown), 
demonstrating primary antibody specificity. 
 
TKTL1 Expression Analysis 
Primers were designed that captured both the mouse and human TKTL1 gene 
sequence (Supplemental Table 1), made possible by the high sequence homology shared 
by mouse and human TKTL1. Real-time RT-PCR was performed using the designed 
primers and RNA from control and hTktl1-pCAGGS transfected HT-22 cells (Protocols 4 
and 5). The results demonstrate that TKTL1 gene expression is millions of times greater 
in hTktl1-pCAGGS transfected cells versus control cells (Figure 2.2); however there is 
no relation to the amount of TKTL1 protein in the cell samples. Since Western blot 
21 
 
analysis revealed human TKTL1 protein in only the hTktl1-pCAGGS transfected cells, it 
is reasonable to assume that total TKTL1 protein content is greater in the sample cells 
than the control cells. Therefore, TKTL1 is overexpressed in hTktl1-pCAGGS transfected 
cells compared to control cells. 
 
 
Figure 2.2 Real-time RT-PCR of TKTL1 in control and hTktl1-pCAGGS transfected HT-
22 cells. TKTL1 transcription level increased by approximately 3 million fold in the 
hTktl1-pCAGGS transfected cells. The translation level of the gene is not reflected. Error 
bars indicate a 95% confidence interval. 
 
Glutathione Assay 
 The Glutathione Assay kit from Cayman Chemical was used to determine the 
amounts of reduced and oxidized glutathione (GSH and GSSG, respectively) in control 
and hTktl1-pCAGGS transfected cells (Protocol 6). The kit relies on a colorimetric 
reaction where GSH reacts with 5,5’-dithio-bis-2-(nitrobenzoic acid) (DTNB) to produce 
5-thio-2-nitrobenzoic acid (TNB), which has a yellow color. GSHTNB is concomitantly 
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produced and reduced by glutathione reductase to recycle the GSH and produce more 
TNB. The rate of TNB production is directly proportional to the GSHTNB to GSH 
reaction, which is directly proportional to the concentration of total glutathione. The 
absorbance of the yellow TNB at 405nm provides an estimation of total glutathione in a 
sample. In order to determine GSH amount alone, GSSG can be measured and subtracted 
from the total glutathione. Measurement of GSSG is performed similarly to total 
glutathione measurement, but with the addition of 2-vinylpyridine to the sample to 
derivatize glutathione. GSH and GSSG concentrations were calculated using the end 
point analysis method. Statistical methods were also used to analyze the data. 
 
Glutathione Assay Results 
Nine different HT-22 cell lines were assayed for GSH and GSSG, four of which 
resulted in negative amounts of GSSG in control and/or hTktl1-pCAGGS transfected 
cells. In other words, the absorbance values were less than the 0mM GSSG standard 
absorbance potentially due to negligible amounts of GSSG, insufficient cell 
concentration, or interference as suggested through communications with Cayman 
Chemical technical support. The cell samples were concentrated as much as possible and 
in some cases resulted in positive amounts of GSSG, while others remained negative.  
Figure 2.3 displays the GSH/GSSG redox ratio for the five trials that resulted in 
positive concentrations. The ratio for trials 3, 6 and 8 decreased upon overexpression of 
TKTL1, while Trials 7 and 9 showed no difference. The GSH/GSSG ratios and standard 
deviations can be found in the supplemental information (Table 2). 
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Figure 2.3 GSH/GSSG in control and hTktl1-pCAGGS transfected HT-22 cells. These 
were the trials that resulted in positive concentration values. TKTL1 overexpression 
resulted in decreased GSH/GSSG  ratios or no difference. Error bars indicate a 95% 
confidence interval. 
 
 The raw absorbance values obtained for all nine glutathione assays were also 
analyzed. Initially, the proportion of GSH in each cell sample was calculated (Table 2.3 
and Figure 2.4) using the formula ( (GSH – GSSG) / GSH). Since GSH in the assay 
represents total glutathione, the absorbance value for oxidized glutathione was subtracted 
from the GSH value to give the value for reduced GSH.  
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GSH / Total Glutathione 
Trial # Control Sample 
1 0.21173 0.15589 
2 0.71477 0.59042 
3 0.57010 0.43391 
4 0.75465 0.74759 
5 0.78521 0.71819 
6 0.47580 0.11955 
7 0.11657 0.12729 
8 0.60528 0.55941 
9 0.38604 0.40499 
 
Table 2.3 Proportion of GSH in control and hTktl1-pCAGGS transfected cells. 
 
 
Figure 2.4 Proportion of GSH in control and hTktl1-pCAGGS transfected cells for all 
nine trials. Five trials resulted in a decreased proportion upon TKTL1 overexpression, 
four trials displayed no change. Error bars indicate a 95% confidence interval. 
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A boxplot was then constructed to visualize the data (Figure 2.5). The boxplot 
illustrates that the proportion of GSH in HT-22 cells decreased upon TKTL1 
overexpression. The decrease is statistically significant (P = 0.029) as determined by a 
one-tailed T-test.  
 
 
Figure 2.5 Boxplot of the proportion of GSH in control and hTktl1-pCAGGS transfected 
HT-22 cells using raw absorbance values (P= 0.029).  
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Glutathione Assay Analysis 
 Taken together, the analysis of the concentrations of GSH and GSSG in control 
and hTktl1-pCAGGS transfected cells and the analysis of the proportion of GSH in the 
cells based on raw absorbance values indicate that TKTL1 overexpression decreases the 
amount of GSH in the cell. Presumably, the cell would not be able to readily reduce free 
radicals, causing a state of oxidative stress. Based on the PPP, TKTL1 indirectly affects 
glutathione through influencing NADPH production. I hypothesized that NADPH will 
also be decreased, providing a mechanism which hinders GSH production. 
 
NADPH Experiments 
 The NADP
+
/NADPH Assay kit from BioAssay was used to determine the ratio of 
NADPH/NADP
+
 in the control and hTktl1-pCAGGS transfected cells (Protocol 7). The 
kit has a procedure to extract NADP
+
 and NADPH from the cells using provided buffers. 
NADP
+
 and NADPH are then measured by a colorimetric reaction where formed 
NADPH reduces a formazan (MTT) reagent, which produces a color that is measured at 
565nm. This color is proportionate to the NADP
+
/NADPH concentration in the sample. 
 
NADPH Assay Results 
 Five different HT-22 cell lines were assayed for NADP
+
 and NADPH. Of the 
five, three displayed a decrease in the NADPH/NADP
+
 ratio upon TKTL1 
overexpression, one increased and one resulted in no change (Figure 2.6). The NADPH 
and NADP
+
 concentrations and their ratio can be found in Supplemental Table 3. 
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Figure 2.6 NADPH/NADP
+
 ratio for trials 1 through 5. TKTL1 overexpression resulted 
in decrease, increase, or no change. Error bars indicate a 95% confidence interval. 
 
NADPH Assay Analysis  
Further analysis of NADPH/NADP
+
 is needed in order to provide a conclusive 
statement about the effect of TKTL1 overexpression on the NADPH/NADP
+
 ratio. The 
results suggest that there is an effect on the NADPH/NADP
+
 ratio since the ratio 
decreased in three out of five trials when TKTL1 was overexpressed. Since GSH was 
demonstrated to decrease, it was expected that NADPH would provide the same result. 
The hypothesized mechanism was that a decrease in NADPH would lead to a decrease in 
GSH, since NADPH reduces GSSG.   
 A decrease in the NADPH/NADP
+
 ratio would indicate that overexpression of 
TKTL1 decreases the amount of NADPH produced by the cell. Since increase, decrease 
and no change were all seen, it is possible that NADPH from other sources in the cell is 
skewing the result. A different assay may be needed to determine the effect of TKTL1 
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overexpression on NADPH/NADP
+
, if any. Based on the Banki et al. paper, it is expected 
that NADPH will be affected. 
 
G6pdx Expression  
Real-time RT-PCR was performed to analyze G6pdx expression in control and 
hTktl1-pCAGGS transfected cells (Protocol 5). Analysis demonstrated a significant 
decrease of G6pdx when TKTL1 was overexpressed (Figure 2.7).  
 
 
Figure 2.7 Real-time RT-PCR of G6pdx, coding for G6PD in mouse, in control and 
hTktl1-pCAGGS transfected HT-22 cells. G6pdx levels significantly decreased upon 
TKTL1 overexpression (P = 0.000135). Error bars indicate a 95% confidence interval. 
  
G6pdx Expression Analysis 
A decrease in G6pdx may lead to a decrease in NADPH production since G6pdx 
catalyzes the production of NADPH. Furthermore, less NADPH would be available in the 
cell to reduce GSSG to GSH, causing a decrease in GSH in the cell and leading to 
oxidative stress.  
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Discussion 
 G6pdx expression decreased due to overexpression of TKTL1. It was thought that 
this decrease would reduce the amount of NADPH produced in the cell. While the results 
point toward this effect, no conclusion can be made about the actual effect, if any, on 
NADPH. Assuming there were less NADPH available, the ability of the cell to reduce 
glutathione would be inhibited. The results demonstrate that the amount of GSH in the 
cell decreased in response to TKTL1 overexpression. Based on this result, I determine 
that the cell is in a state of oxidative stress due to overexpression of TKTL1. To confirm 
this, direct analysis of reactive oxygen species (ROS) levels would be necessary. 
Increased ROS levels are expected based upon the results of this study and would support 
the conclusion of oxidative stress. The increase in ROS levels would also increase the 
cell’s sensitivity to apoptosis, which is measurable as well. This was the result upon TAL 
overexpression
42
 and I hypothesize the same effect for TKTL1 overexpression. Therefore, 
future analysis may conclude that TKTL1 levels in the cell play a role in programmed cell 
death. 
ROS, including superoxide, hydroxyl, hydrogen peroxide, singlet oxygen and 
nitric oxide, cause cellular damage and maintain importance in autism
43
. Increased ROS 
levels have been found in patients with autism, as well as in other neuropsychiatric 
conditions
44. Impairment in the cell’s antioxidant defense system may contribute to this 
increase. Patients with autism have a decreased amount of reduced GSH compared to 
unaffected individuals
45
 which decreases the cell’s capacity to reduce ROS and leads to 
oxidative stress. It is unclear, however, if oxidative stress contributes to the pathogenesis 
of autism, or if it is a secondary manifestation of the disorder
45
. 
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Chapter 3: Human Lymphoblast Autism Studies 
 
3.1 Background Information 
Autism 
Autism is a neurodevelopmental syndrome with genetic and nongenetic causes, 
characterized by a variety of phenotypes. According to the Diagnostic and Statistical 
Manual of Mental Disorders: DSM-IV-TR there are three criteria for diagnosing autism: 
impairment in 1) social interaction and 2) communication and 3) restricted patterns of 
behavior, interests and activities. If a patient has severe impairment in several criteria but 
not all, the DSM-IV-TR identifies the disorder as pervasive developmental disorder, or 
autism spectrum disorder (ASD) including autistic disorder, Rett’s Disorder, childhood 
disintegrative disorder, Asperger’s disorder, and pervasive developmental disorder not 
otherwise specified. 
Nongenetic factors, such as oxidative stress, contribute to the pathogenesis of 
autism and several other neuropsychiatric disorders due to the brain’s vulnerability to 
oxidative stress
46
. Research shows lowered levels of the antioxidant enzymes glutathione 
peroxidase and superoxide dismutase in autistic individuals, denoting impaired 
antioxidant defense mechanisms
47
. Additionally, patients with autism displayed reduced 
levels of total glutathione and a lowered GSH/GSSG redox ratio
48
. Supplementation with 
methyl B12 improved blood glutathione levels and the GSH/GSSG redox ratio in 30% of 
test subjects, indicating methyl B12 as a potential beneficial autism treatment
49
. Genetic 
and environmental effects may increase vulnerability to oxidative stress in autism. 
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Inconsistent linkage and association results
50
, as well as low sibling recurrence 
compared to single-gene diseases
51
, support the genetic complexity of autism. Multiple 
genetic loci on several chromosomes have been linked to autism or ASD
52
. While some 
genes are directly linked to autism, others are thought to contribute indirectly by 
increasing an individual’s susceptibility to the disorder. The complex inheritance patterns 
formed by the combination of multiple genes that interact with each other and the 
environment remain unknown. Recently, de novo copy number variation mutations have 
been associated with a subset of ASD cases, typically of individuals with older fathers, 
leading researchers toward a new mode of inheritance
53
. One example is the 
chromosomal region 15q11-q13
54
. This region is an original region associated with 
autism and is also imprinted in Angelman and Prader-Willi syndromes (AS and PWS, 
respectively)
55
. An imprint mutation causes either AS or PWS depending on parental 
mode of inheritance. 
Several disorders are consistently associated with ASD, such as fragile X, 
Angelman and Prader-Willi syndromes, among others, however these cases account for 
only a small percentage of ASD diagnoses. Notably, all ASD-related syndromes are 
limited to the brain
56
. 
Genome-wide association studies (GWAS) are becoming increasingly important 
in the study of autism. GWAS have demonstrated that not only is rare variation important 
in autism, but common variation is as well. GWAS have identified regions and single 
nucleotide polymorphisms linked or associated with autism. The chromosomal region 
15p14.1 is an example of a common variation region
57
. Two genes previously connected 
to ASD, RyR2 and UPP2, were also identified by GWAS as autism-associated genes
58
. 
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Autism is diagnosed four times as often in males as in females indicating 
involvement of an X-linked imprinted gene in autism
59
. Turner syndrome studies by 
Skuse et al. point toward an X-linked gene that is paternally expressed
60
.  
 
Turner Syndrome and Skuse Hypothesis  
 Turner syndrome is characterized by complete or partial absence of one X 
chromosome in some or all of a female’s cell lines due to failed sex chromosome 
segregation. Turner individuals tend to have clinical problems, such as cardiovascular 
and kidney problems, and exhibit social behavior problems; however their intelligence is 
typically normal. Skuse et al. found that differences in social behavior could distinguish 
45,X
p
 females from 45,X
m
 females
60
. The study showed that 46,XX and 45,X
p
 females 
had superior social cognitive skills than 46,X
m
Y males and 45,X
m
 females indicating that 
a gene expressed only from the paternal X chromosome is involved in social behavior
60
. 
If an X-linked imprinted locus is responsible for social behavior differences this may 
explain why males tend to be affected more often than females by pervasive 
developmental disorders affecting social behavior, such as autism. 
Researchers proposed that a maternal imprint on the X chromosome lowers the 
threshold for phenotypic expression of the genes predisposing an individual to autism
61
. 
Particularly, this explains the male vulnerability to autism. Looking at this proposal 
another way, the imprint protects females from developing the disorder. 
Another theory is the Baron-Cohen fetal testosterone exposure theory
62
. Baron-
Cohen proposed that fetal exposure to high androgen levels is associated with increased 
severity of some autistic traits, irrespective of sex chromosome constitution. He called 
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this the “extreme male brain.” The male brain type is defined as one that is superior in 
understanding physical objects over social common-sense; a female brain type is opposite 
of this. Individuals are assumed to fall within a continuum in regard to male and female 
brain types. Furthermore, an individual may be “cognitively balanced” where they show 
equal male and female brain types. Baron-Cohen suggested that autistic individuals have 
an extreme male brain type, regardless of sex. Depending on how extreme the male brain 
type is, an individual would fall on a continuum ranging from a touch of autism to 
classical autism. It remains controversial as to the neurobiological composition of a male 
versus female brain. 
 
3.2 Human Lymphoblast Studies 
 As described previously, oxidative stress has been implicated in the pathogenesis 
of autism. My study indicates that TKTL1 overexpression increases oxidative stress, 
providing a potential connection to autism. Consequently, I aimed to determine if there is 
a higher level of TKTL1 expression in relation to autism. 
Family studies were executed for comparison of TKTL1 expression levels in 
autistic individuals versus their unaffected siblings. Human lymphoblastoid cell lines 
were obtained from Rutgers University Cell and DNA Repository. The cell lines 
belonged to individuals affected with autism or ASD (as diagnosed by the DSM-IV) and 
their unaffected siblings.  
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TKTL1 Expression Results 
The lymphoblastoid cell lines of siblings from six pedigrees were brought up in 
cell culture according to procedures provided by Rutgers University Cell and DNA 
Repository (Protocol 8). Total RNA was extracted from the obtained lymphoblastoidal 
cell pellets and was analyzed for TKTL1 expression by real-time RT-PCR (Protocol 9). 
All real-time RT-PCR results are located in Supplemental Figures 2 through 8. The real-
time RT-PCRs were repeated one or more times from the same total RNA.  
The graphs in Figures 3.1 through 3.4 represent the autistic and unaffected males 
from the pedigrees that contained both types of males. We were more interested in 
comparing males to each other because of skewed X-inactivation patterns in female 
lymphoblastoid cell lines. Female lymphoblastoid cell lines tend to be mostly XiX or 
XXi, whereas male lymphoblastoid cell lines will always have an active maternal X 
chromosome. Since TKTL1 is imprinted on the paternal X-chromosome,   X-inactivation 
patterns in the cultured female lymphoblasts may therefore skew the TKTL1 expression 
results. 
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Pedigree 72-0890 
 
 
Figure 3.1 Real-time RT-PCR results for TKTL1 expression in autistic and unaffected 
males for pedigree 72-0890. Error bars indicate a 95% confidence interval. 
  
Pedigree 72-0890 displayed autistic male 03C23215 as having the highest TKTL1 
expression level. Following, autistic male 03C23216 and unaffected male 03C23218 had 
similar expression levels to each other. Unaffected male 03C23228 displayed the lowest 
TKTL1 expression; however the 95% confidence interval was very large. 
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Pedigree 74-0264 
 
 
Figure 3.2 Real-time RT-PCR results for TKTL1 expression in autistic and unaffected 
males for pedigree 74-0264. Error bars indicate a 95% confidence interval. 
  
Unaffected male 03C16525 displayed the highest TKTL1 expression level in 
pedigree 74-0264. The other unaffected male, 03C16522, had the lowest expression, 
while autistic male 03C16523 displayed an expression level in between the unaffected 
males, though closer to 03C16522. 
1.3449
3.1748
12.9804
0
2
4
6
8
10
12
14
16
18
Male                 
03C16522
Autistic Male    
03C16523
Male                 
03C16525
R
e
la
ti
ve
 E
xp
re
ss
io
n
 R
at
io
Pedigree 74-0264
37 
 
Pedigree 61-3511 
 
 
Figure 3.3 Real-time RT-PCR results for TKTL1 expression in autistic and unaffected 
males for pedigree 61-3511. Error bars indicate a 95% confidence interval. 
 
 An autistic male (01C06845) again displayed the highest expression of TKTL1 in 
pedigree 63-3511. The other autistic male (01C06844) and the unaffected males 
(01C06843 and 01C06845) had expression levels similar to each other but lower than 
autistic male 01C06848. 
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Pedigree 63-156 
 
 
Figure 3.4 Real-time RT-PCR results for TKTL1 expression in autistic and unaffected 
males for pedigree 63-156. Error bars indicate a 95% confidence interval. 
 
 Finally, pedigree 63-156 contained one unaffected male and one autistic male. 
They appear to similarly express TKTL1; however there may be a chance that male 
01C07337 expresses TKTL1 at a higher level than autistic male 01C07335. The large 
error bars make this relationship difficult to determine. 
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TKTL1 Expression Analysis 
 It appears that autistic males may have approximately equal or higher TKTL1 
expression than unaffected male siblings, with one exception. Autistic male 03C16523 in 
pedigree 74-0264 had lower expression than one of his unaffected brothers (03C16523).  
 The results for the males analyzed in the above four pedigrees were analyzed 
together and combined into autistic and control (unaffected) groups. Figure 3.5 displays 
the individuals’ TKTL1 expression levels along with their averaged expression. The two 
groups appear to have similar TKTL1 expression according to this analysis, with a fairly 
similar distribution of individual expression. A one-tailed T-test determined that there 
was no significant difference of TKTL1 expression between autistic and unaffected 
groups (P = 0.41417).    
 
 
Figure 3.5 TKTL1 expression in autistic and control (unaffected) males from pedigrees 
72-0890, 74-0264, 61-3511 and 63-156. Diamonds indicate individual expression levels 
for each male. Error bars indicate standard error. 
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 An analysis of variance (ANOVA) was performed by Dr. Nathaniel Jue to further 
analyze the data. The results of the ANOVA are provided in Tables 3.1 and 3.2. The test 
indicates that there is no significant difference of TKTL1 expression between autistic and 
unaffected individuals. Additionally, both autism (fixed factor) and family (random 
factor) have no significant effect on TKTL1 expression. 
 
Source DF Sum of Squares Mean Square F Ratio 
Model 4 16.888646 4.22216 0.7623 
Error 8 44.309982 5.53875 Prob > F 
C. Total 12 77.814871  0.5782 
 
Table 3.1 Analysis of Variance. 
 
 
Source Nparm DF DFDen Sum of Squares F Ratio Prob > F 
Autistic 1 1 8 0.20472 0.0368 0.8526 
FamilyID & Random 4 3 8 16.545622 0.9957 0.4428 
 
Table 3.2 Effects Tests. 
 
Discussion 
 The information in Figure 3.5 and Tables 3.1 and 3.2 suggests that TKTL1 
expression differences do not exist between autistic and unaffected individuals. However, 
it must be taken into account that the sample size is relatively small.  In total, thirteen 
males from four families were included in the above figure, which may not be 
representative of the larger population. The potential differences in TKTL1 expression 
that are implicated in Figures 3.1 through 3.4 may also be misleading because of two 
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problems: real-time RT-PCR Ct values varied within triplicates for an individual and 
relative expression ratios varied for an individual between trials. 
 Observation of the Ct values for both GAPDH and TKTL1 revealed variation 
within the triplicates for a single individual. Variation could be attributed to poor primer 
design or old primers that degraded. Originally, polyA selected mRNA had been used for 
real-time RT-PCR, along with a different TKTL1 primer set. TKTL1 was difficult to 
amplify with these primers and produced poor melt curves. I discovered that the forward 
primer of that set had been designed to pick up a wild type SNP in the 5’ UTR of TKTL1. 
With this knowledge, I decided that this was an unacceptable primer set to use and 
instead made a primer set spanning exons 4 and 5 of the gene. The new primer set 
amplified TKTL1 well from total RNA and the polyA mRNA selection was abandoned. 
For a period of time the Ct values had little variation within the triplicates, however 
within two months the Ct values started to vary. Since the GAPDH Ct values had not 
previously varied, I ordered the same primers again. Even with fresh primers the Ct 
values continued to vary within triplicates. Re-ordering the same GAPDH primers 
demonstrated that the variation was probably not due to degraded primers seeing as the 
issue persisted. It is also interesting to note that both sets of primers had previously 
amplified the genes well and consistently. 
 The variation of Ct values within the triplicates for a single individual and the 
occurrence of this happening for both primer sets caused two problems with the real-time 
RT-PCR results. First, many error bars on the graphs are very large, meaning that the 
95% confidence intervals are very large. Repeating the real-time RT-PCRs did not fix 
this, however repetition caused the second problem to become apparent. Between trials 
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the relative expression of TKTL1 among individuals changed even though the same RNA 
was used. For example, in pedigree 61-3511 on 3/30/11 autistic male 01C06844 
displayed higher TKTL1 expression than male 01C06848; however that relationship 
switched on 3/31/11 (Supplemental Figure 2.6). For this reason I took into account the 
data from all repetitions of pedigrees 61-3511 and 63-156 for the above analysis of 
unaffected males versus autistic males, however in actuality the relationships may be 
different. The data from only one trial each of pedigrees 72-0890 and 74-0264 was used 
for the above analysis because even larger error bars would have been introduced if more 
data was included. Again, the relationship between individuals may not be accurately 
represented. 
 While GAPDH has been used as a reference gene in many publications, 18S 
rRNA is less variable in expression level than GAPDH and therefore may be a better 
candidate for a reference gene. GAPDH mRNA levels are not constant
63
 and expression 
level variability was found in Epstein-Barr virus-transformed lymphoblastoid cell lines
64
. 
Another possibility is that both primer sets were poorly designed and for an unknown 
reason were able to consistently amplify for some triplicates in earlier real-time RT-
PCRs. Primer instability and degradation are also concerns. Fresh primer dilutions were 
made for each real-time RT-PCR, introducing freeze-thaw effects. Masters mixes were 
used whenever possible to prevent sample-to-sample and well-to-well variability; 
however automation of the sample preparation would reduce inconsistencies. It is also 
possible that the RNA degraded over time, possibly due to freeze-thawing the RNA on 
multiple occasions, or possible nuclease contamination. Variability could also be caused 
by lot-to-lot inconsistencies of reverse transcriptase and SYBR
®
 Green
65
. 
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 An alternative explanation exists for the varied TKTL1 expression between 
autistic and unaffected males between pedigrees. The variation could be due to an 
interaction between autism and family. TKTL1 may be contributing to autism only in 
some families while in others it has little or no effect. The intersecting lines in the graph 
in Figure 3.6 demonstrate a potential interaction between autism and family. However, 
the interaction between a fixed and random variable cannot be tested for given the 
experimental design and statistical approach implemented in this study.  
 
 
 
Figure 3.6 Graph depicting the autistic and control mean relative TKTL1 expression ratio 
in each family. FamilyIDs: 1 = 74-0264, 2 = 61-3511, 3 = 63-156, 4 = 72-0890.  
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Chapter 4: Synopsis 
 Oxidative stress has been implicated in the pathogenesis of autism. The pentose 
phosphate pathway is responsible for combating oxidative stress by reducing glutathione, 
which subsequently reduces free radicals. Previous studies have shown a decreased 
GSH/GSSG ratio and an increased free radical generation in lymphoblastoid cells of 
autistic and unaffected individuals
45
. Additionally, the amount of reduced glutathione in 
the cell is decreased when transaldolase is overexpressed
42
. Combined, there is reason to 
believe that TKTL1 overexpression causes a decreased ability of the cell to reduce 
glutathione. 
 Overexpression of TKTL1in this study significantly decreased the GSH/GSSG 
ratio in the cell, indicating a heightened state of oxidative stress. It was thought that the 
NADPH/NADP
+
 ratio would decrease as well, however inconclusive results were 
obtained and further testing is required. G6pdx expression, however, did decrease upon 
TKTL1 overexpression. The decrease of both the GSH/GSSG ratio and G6pdx expression 
lead me to hypothesize that the NADPH/NADP
+
 ratio actually decreases as well.  
 Skuse et al. suggested that an X-linked imprinted gene is involved in autism
60
, 
leading us to analyze autistic and unaffected individuals for TKTL1 expression 
differences. It was thought that TKTL1 expression may be higher in autistic individuals 
because of its apparent effect on oxidative stress; however no conclusive deduction could 
be made about TKTL1 expression differences between individuals.    
Potential autism susceptibility genes have been analyzed directly in brain tissue 
using real-time RT-PCR
66
. Since the brain is highly susceptible to the effects of oxidative 
stress, analysis of TKTL1 expression in brain tissue would prove highly informative.  
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Chapter 5: Methods 
 
Protocol 1: TKTL1 Expression Construct Formation 
The full-length human TKTL1 CDS (Open Biosystems clone #4825931) was 
inserted into a pCAGGS vector (Supplemental Figure 1), which contains a chicken β-
actin promoter. Both were digested with EcoRI and then ligated together with T4 DNA 
ligase as per standard methods. Successful construct formation was determined by 
BamHI digest and DNA sequencing. The hTktl1 primers used for sequencing can be 
found in Supplemental Table 1.  
 
Protocol 2: Expression of TKTL1 
The TKTL1 expression construct (hTktl1-pCAGGS) was co-transfected with 
GFP-pCAGGS into HT-22 cells, a mouse hippocampal cell line. T75 flasks were seeded 
with 1x10
6
 cells in 10mL of media (DMEM, 10% FBS, 1% L-glutamine, 1% 
penicillin/streptomycin) and incubated overnight at 37˚C, 5% CO2. A transfection mix 
was then prepared with 750µl DMEM, 3µl Lipofectamine
TM
 PLUS
TM
 Reagent, 1µg GFP-
pCAGGS and 1µg control (empty pCAGGS vector) or hTktl1-pCAGGS. This was 
incubated at room temperature for 5 minutes, then 9µl of Lipofectamine
TM
 LTX was 
added and this was incubated at room temperature for 30 minutes. The transfection mix 
was added to the T75 flasks along with 3mL of media (DMEM, 10% FBS, 1% L-
glutamine) and incubated for 5 hours at 37˚C, 5% CO2. The media was then changed to 
the antibiotic-containing media above. The cells were incubated for 3 days, with a media 
46 
 
change on day 2. On day 3 the cells were imaged and harvested. The cells were harvested 
in ice cold 1x PBS using a rubber policeman. Cell pellets were stored at -80˚C.  
 
Protocol 3: Western Blot   
 Western blot was performed using cell pellets and established protocols. The 
primary antibody was a monoclonal mouse anti-human TKTL1 antibody (Abcam
®
). The 
secondary antibody was stabilized Peroxidase Conjugated Goat anti-Mouse (H + L) 
(Thermo Scientific). After blotting, proteins were detected using Western Lightning
®
 
Plus-ECL (PerkinElmer). 
 
Protocol 4: Total RNA Extraction 
 Total RNA was extracted from cell pellets using the RNeasy Mini Kit (QIAGEN) 
as per manufacturer’s instructions. The RNA was subsequently DNased using TURBO 
DNA-free™ (Ambion®). 
 
Protocol 5: Real-Time RT-PCR 
 cDNA synthesis was performed with 1µg of RNA using a qScript cDNA 
Synthesis kit (Quanta BioSciences, Inc.™) as per manufacturer’s protocol. Real-time RT-
PCR was performed using PerfeCTa
®
 SYBR
®
 Green FastMix
®
 for iQ (Quanta 
BioSciences, Inc.™) and primers “AF TKTL1 F1” and “AF TKTL1 R1” for 
TKTL1/Tktl1, “G6pd F” and “G6pd R” for G6pdx, and “MF3” and “MR3” for mouse β-
actin (Supplemental Table 1). The cycling conditions were as follows: 95˚C for 3 min, 40 
cycles of 95˚C for 10 secs and 63.5˚C (for TKTL1/Tktl1) or 63˚C (for G6pdx) for 30 secs, 
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95˚C for 1 min, 55˚C for 1 min, 80 cycles of 55˚C for 10 secs + 0.5˚C/cycle. 
Mathematical analysis of real-time RT-PCR data was carried out as described by 
normalizing and comparing Ct values of the genes of interest to  -actin
67
. 
 
Protocol 6: Glutathione Assay 
 Cell pellets were homogenized in the appropriate buffer and then deproteinated 
using metaphosphoric acid (Sigma-Aldrich
®
). Deproteinated samples were assayed with 
the Glutathione Assay Kit (Cayman Chemical). As per manufacturer’s instructions, total 
GSH was detected via a colorimetric reaction with DTNB. GSSG was detected by 
addition of 2-vinylpyridine (Sigma-Aldrich
®
) prior to assaying. A 96-well plate reader 
was used to measure the absorbance at 405nm at 5 minute intervals over a period of 30 
minutes. The 25 minute read was used for the end-point analysis. End point analysis: 
[(sample absorbance – standard y-intercept) / (standard slope)] * 2. All values were 
determined per manufacturer’s protocol. 
 
Protocol 7: NADP
+
/NADPH Assay 
 Cell pellets were homogenized in provided buffers from the EnzyChrom™ 
NADP
+
/NADPH Assay Kit (BioAssay Systems). As per manufacturer’s protocol, 
NADP
+
 and NADPH were measured via a colorimetric reaction based on the ability of 
NADPH to reduce tetrazolium dye (MTT). A 96-well plate reader was used to measure 
the absorbance at 565nm at time “zero” and after a thirty minute incubation at room 
temperature. OD0 was subtracted from OD30 and the ∆OD was used to calculate the 
NADP
+
 and NADPH concentrations using the standard curve. 
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Protocol 8: Human Lymphoblastoid Cell Culture 
Human lymphoblastoid cell lines were received from Rutgers University Cell and 
DNA Repository at Rutgers, The State University of New Jersey, per NIMH permission. 
The cell lines consisted of lymphoblasts from individuals affected with autism or ASD 
(as diagnosed by the DSM-IV) and unaffected siblings. The cell lines were received as 
1mL aliquots cryopreserved in 45% RPMI-1640, 50% FBS and 5% DMSO.  
10mL of fresh media (88% RPMI-1640, 10% FBS, 1% penicillin/streptomycin 
and 1% nonessential amino acids) was added to T-75 flasks. The cell lines were thawed 
at 37˚C and pipetted into one flask each. 10mL of media was added to each flask 24 
hours later. Fresh media was added as needed to maintain a cell density between 200,000 
cells/mL and 500,000 cells/mL. Cells were collected as necessary. 
When collected, the cell lines were either frozen down or stored as pellets. In both 
cases, the cell suspension was centrifuged at 1,000 x g for 5 minutes at 4˚C and then the 
media was removed. To freeze down, the cells were resuspended in freezing media (90% 
media from above and 10% DMSO) and 1mL aliquots were stored in cryotubes in liquid 
nitrogen. The cell pellets were stored at -80˚C. 
 
Protocol 9: Human Lymphoblastoid Real-Time RT-PCR 
 Total RNA was extracted from the human lymphoblastoid cell pellets using 
TRIzol
®
. Subsequently cDNA was prepared as per manufacturer’s protocol (qScript™ 
cDNA Synthesis kit, Quanta BioSciences, Inc.™). Real-time PCR was performed using 
PerfeCTa 
®
 SYBR
®
 Green FastMix
®
 for iQ (Quanta BioSciences, Inc.™) as per usual 
methods using the primers “AF hTktl1 F14” and “AF hTktl1 R14” for TKTL1 and 
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“hGAPDH F” and “hGAPDH R” for GAPDH (Supplemental Table 1). The cycling 
conditions were as follows: 95˚C for 3 min, 40 cycles of 95˚C for 10 secs and 63˚C for 30 
secs, 95˚C for 1 min, 55˚C for 1 min, 80 cycles of 55˚C for 10 secs + 0.5˚C/cycle. 
Mathematical analysis of the data was carried out as described by normalizing the Ct 
values of TKTL1 to GAPDH and comparing the relative expression ratios
67
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Chapter 6: Supplemental Information 
  
 
Figure 1 pCAGGS vector map. Commercially available expression vector used for 
TKTL1 transfection into HT-22 cells. The TKTL1 CDS was inserted at the EcoRI sites. 
Image provided by the LoTurco laboratory.  
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Figure 2 Two separate real-time RT-PCR trials of pedigree 72-0890. Error bars indicate 
a 95% confidence interval.  
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Figure 3 Two separate real-time RT-PCR trials for pedigree 72-1650. Error bars indicate 
a 95% confidence interval.  
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Pedigree 74-0264 
 
 
Figure 4 Real-time RT-PCR results for one trial of half of pedigree 74-0264. These 
individuals are cousins with the other half of this pedigree (shown below). Error bars 
indicate a 95% confidence interval.  
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Figure 5 Real-time RT-PCR results for two separate trials of half of pedigree 74-0264. 
These individuals are cousins with the other half of this pedigree (shown above). Error 
bars indicate a 95% confidence interval.  
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Pedigree 63-302 
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Figure 6 Real-time RT-PCR results for two separate trials of pedigree 63-302. Data was 
not available for Autistic Female 01C05902 and Autistic Male 01C05905. Error bars 
indicate a 95% confidence interval.  
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Pedigree 61-3511 
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Figure 7 Real-time RT-PCR results for three separate trials of pedigree 61-3511. Error 
bars indicate a 95% confidence interval.  
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Pedigree 63-156 
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Figure 8 Real-time RT-PCR results for two separate trials of pedigree 63-156. Data was 
not available for Female 01C07334 on 4/1/11. Error bars indicate a 95% confidence 
interval. 
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Primer Name Sequence (5'→ 3') Gene 
   M13 F CAGGAAACAGCTATGAC Vector 
M13 R GTAAAACGACGGCCAG Vector 
AF pCAGGS F4 TTCAGACTCCAAAGGGGTTG pCAGGS Vector 
hTktl1 F7 (Operon) ATGCCGAGAGAAAGAGCAGA TKTL1 
hTktl1 F7 (Invitrogen) GCATATGCAAGTACCGCTCT TKTL1 
hTktl1 F11 GAGGCGAGGGCTGAGTTC TKTL1 
hTktl1 R3 AAACATAAACACAGGGTAAAGAGGC TKTL1 
hTktl1 R5 TTCTGAGGACTCGCCATCACTC TKTL1 
hTktl1 R10 TTCAATCCACATTTTCTTTACTCATG TKTL1 
hTktl1 R13 GGCATCTGCTCTTTCTCTCG TKTL1 
hTktl1 R15 AATTCCTCGGACTTCCCACT TKTL1 
hTktl1 R16 CGGATTCTCTGGATCTGACTG TKTL1 
Actb MF3 ACACCCGCCACCAGTTCG β-Actin 
Actb MR3 CGATGGAGGGGAATACAGCC β-Actin 
AF TKTL1 F1 ATGTGGCAACAGGATGGC TKTL1/Tktl1 
AF TKTL1 R1 TGGTCTGTATCTGGCTCTCAATTAA TKTL1/Tktl1 
G6pd F AGCCTCCTATAAGCACCTCAACAGCC G6pdx 
G6pd R TCCACGATGATGCGGTTCCAGC G6pdx 
hGAPDH F AACTTTGGTATCGTGGAAGG GAPDH 
hGAPDH R ACACGTTGGCAGTGGGGACA GAPDH 
AF hTktl1 F14 TCTGTCTGGGAGGCAATGGCC TKTL1 
AF hTktl1 R14 TCCCGGCCGTCCACCACATAA TKTL1 
 
Table 1 Name, sequence and gene for the primers used throughout the thesis. 
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Trial # Control/Sample Average GSH/GSSG Standard Deviation 
1 Control NA NA 
 Sample NA NA 
2 Control NA NA 
 Sample NA NA 
3 Control 7.32768 0.42949 
 Sample 2.82402 0.15848 
4 Control NA NA 
 Sample NA NA 
5 Control NA NA 
 Sample NA NA 
6 Control 8.95068 1.23647 
 Sample 1.34007 0.12721 
7 Control 1.23923 0.12119 
 Sample 1.27867 0.21110 
8 Control 9.14736 0.25454 
 Sample 6.02062 0.21985 
9 Control 3.49679 0.09919 
 Sample 3.36254 0.11754 
 
Table 2 Glutathione assay results.  “NA” (Not Applicable) in the GSH/GSSG column 
means that the ratio could not be determined because the GSSG concentration was 
negative.  
 
 
Trial # Control/Sample Average NADPH/NADP+ Standard Deviation 
1 Control 0.67111 0.25864 
 Sample 0.90285 0.04089 
2 Control 1.03492 0.19806 
 Sample 0.51953 0.06389 
3 Control 5.37500 NA 
 Sample 0.79070 NA 
4 Control 0.62909 0.02542 
 Sample 0.46992 0.02570 
5 Control 0.23906 0.02241 
 Sample 0.30233 NA 
 
Table 3 NADP
+
/NADPH assay results. “NA” indicates that the standard deviation could 
not be calculated because only one sample in the triplicate provided usable data. 
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